To the full analysis
Ecolab stock: growth
ECLEcolab reported $16.08B in revenue for fiscal 2025, up 2.2% on the prior year, up 6.4% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
6.5%
per year from 2006 to 2025, per share 5.8%
Earnings (Annual rate)
9.5%
per year from 2006 to 2025, per share 8.9%
Free cash flow (Annual rate)
10.1%
per year from 2006 to 2025, per share 9.4%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.4% | 1.7% | 6.5% |
| Revenue per share | 6.7% | 2.2% | 5.8% |
| Earnings | no data | 7.6% | 9.5% |
| Earnings per share | no data | 8.0% | 8.9% |
| Free cash flow | 6.8% | 4.9% | 10.1% |
| Free cash flow per share | 7.1% | 5.3% | 9.4% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.9B | $368.62M | $306.63M |
| 2007 | $5.47B | $427.2M | $436.1M |
| 2008 | $6.14B | $448.1M | $358.7M |
| 2009 | $5.9B | $417.3M | $397.7M |
| 2010 | $6.09B | $530.3M | $652.7M |
| 2011 | $6.83B | $462.5M | $319.5M |
| 2012 | $11.84B | $703.6M | $595.5M |
| 2013 | $13.25B | $967.8M | $897.5M |
| 2014 | $14.28B | $1.2B | $1.02B |
| 2015 | $13.55B | $1B | $1.18B |
| 2016 | $13.15B | $1.23B | $1.18B |
| 2017 | $13.84B | $1.5B | $1.22B |
| 2018 | $14.67B | $1.43B | $1.43B |
| 2019 | $12.56B | $1.56B | $1.69B |
| 2020 | $11.79B | −$1.21B | $1.37B |
| 2021 | $12.73B | $1.13B | $1.42B |
| 2022 | $14.19B | $1.09B | $1.08B |
| 2023 | $15.32B | $1.37B | $1.64B |
| 2024 | $15.74B | $2.11B | $1.82B |
| 2025 | $16.08B | $2.08B | $1.9B |
Revenue by segment
How Ecolab Inc. makes its money and how that has shifted. Names are as the company reports them.
- Global Water$8.0B50%
- Global Institutional and Specialty$6.1B38%
- Global Life Sciences$747.9M5%
- Other$1.2B8%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Global Water | $7.98B | 49.6% |
| Global Institutional and Specialty | $6.1B | 38% |
| Global Life Sciences | $747.9M | 4.7% |
| Other | $1.25B | 7.8% |
| Total revenue | $16.08B | 100% |
Revenue by region
Where Ecolab Inc. generates its revenue.
- United States53%
- Europe20%
- Asia Pacific8%
- Latin America7%
- C [N]4%
- Middle East and Africa4%
- Other3%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| United States | $7.42B | $8.12B | $8.31B | $8.48B | 52.7% |
| Europe | $2.96B | $3.22B | $3.19B | $3.28B | 20.4% |
| Asia Pacific | $1.21B | $1.3B | $1.34B | $1.36B | 8.5% |
| Latin America | $860.6M | $1.01B | $1.1B | $1.1B | 6.8% |
| C [N] | $683.6M | $670.3M | $696.9M | $722.4M | 4.5% |
| Middle East and Africa | $509.3M | $552.9M | $625.2M | $638.2M | 4% |
| Other | $540M | $453.1M | $478.7M | $499.4M | 3.1% |
| Total revenue | $14.19B | $15.32B | $15.74B | $16.08B | 100% |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 10 Nov 2026, previously Neutral
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.